Lupus anticoagulant (LA)
Coagulation · also called LA screen, dRVVT, Lupus inhibitor
What it measures
Detects antiphospholipid antibodies that prolong phospholipid-dependent clotting tests in vitro but increase clot risk in the body. Part of the work-up for antiphospholipid syndrome, recurrent thrombosis and pregnancy loss.
Specimen and preparation
- Specimen: Double-centrifuged, platelet-poor citrated plasma
- Tube: Light_blue top
- Preparation: Test when not on anticoagulants if possible; DOACs and heparin cause false results. Repeat positives after 12 weeks.
Reference range
| Group | Range |
|---|---|
| dRVVT screen/confirm ratio | <1.2 (negative) ratio |
| All | Not detected |
Reference ranges differ between laboratories, methods and populations. Always use the range printed on your own lab report.
Causes of high values
- Positive: antiphospholipid syndrome
- Systemic lupus erythematosus
- Infections and certain drugs (transient)
- Anticoagulant interference (false positive)
Method
Two tests: dilute Russell viper venom time (dRVVT) and LA-sensitive aPTT, each with screen, mix and confirm steps
Good to know
Diagnosis of antiphospholipid syndrome requires persistent positivity plus clinical events; combine with anticardiolipin and anti-β2-glycoprotein I antibodies.
Related tests
📱 Practise with a timer, track your score and earn certificates in the free MLT Globe app – Google Play or practise online.